CERUS CORP cotiza a 2.26 USD y tiene una capitalización bursátil de $455M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathoge…
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.01 | $-0.01 | $-0.01 |
| Estimado | $-0.01 | $-0.01 | $-0.04 | — |
| Sorpresa | — | +0.0% | +75.0% | — |
| Métrica | CERS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -3.7% | -38.6% | +34.9% |
| Net Margin | -6.7% | -33.6% | +26.9% |
| FCF Margin | 0.5% | -13.9% | +14.3% |
| ROE | -24.3% | -40.4% | +16.1% |
| ROA | -7.0% | -32.0% | +25.0% |
| Current Ratio | 1.73 | 2.84 | -1.11 |
| Debt / Equity | — | 0.28 | — |